In the ultra-competitive world of cannabis retail, operators are looking for new ways to stand out from the pack, and one option some have decided to go with is opening a themed dispensary with a focus on creating an “immersive” and dare-we-say “Instagrammable” experience.

Surging demand for cannabis in Canada, California, and Massachusetts drove a 45.7% increase in global sales during 2019, according to researchers at Arcview and BDS Analytics.

They crunched the numbers and calculated that legal marijuana sales reached $14.9 billion last year. Recreational sales in Canada, California, and Massachusetts were credited with driving the strong upswing, while flourishing medical sales in Florida and Oklahoma also took some of the credit.

The time it takes for an edible to hit and the variances in your digestive system on any given day can result in an overdose.

Among the myriad ways of consuming cannabis, edibles are the most unpredictable. Resulting in powerful highs that take their sweet time to get there, edibles produce an equal amount of love and fear from cannabis veterans and newbies alike. Here’s why these products are so different than smoking or vaping cannabis.

Cannabidiol (CBD) is the most dominant, non-psychoactive cannabinoid found in the cannabis plant, second only to THC.

There are numerous ways to utilize this compound, but with nearly every method, the CBD needs to be extracted from the plant matter. It also needs to be purified so it can be used in high-end products and medications, and this is where CBD Distillate comes into play.

One theory is that cannabis can influence a person’s level of insulin, thus, influencing their waistline.

Despite the munchies and the couch potato stereotype that plagues marijuana users, some studies link thinner waistlines with cannabis consumption, even when factors such as age, physical activity and gender are accounted for. These results have led scientists believe that the endocannabinoid system could have some influence over our eating patterns and metabolism.

The use of CBD in the health and wellness products has been shown to be helpful in relieving pain and inflammation, as well as functioning as a natural sleep aid. However, in order for CBD to be effective, it needs to be taken either orally or topically in a manner where the CBD can actually get absorbed into the body.

CBD’s takeover and introduction into the mainstream has been unprecedented, making many well-known business eager to get involved.

CBD has been called the “next gold rush” so many times that the phrase is starting to lose its impact. Still, the numbers don’t lie, and everything suggests that CBD wellness products are here to stay.

Television today is all about streaming services that are pushing out content faster than people can watch it. And that means  there are a lot of great shows at your fingertips that aren’t held back by traditional cable regulations around language, nudity and “mature themes.” Some streaming services have adopted new policies.

Netflix announced last summer that in all future shows aimed at younger audiences there will be no smoking or e-cigarettes unless it’s historically or factually accurate. What all this means is, many characters currently on TV can smoke weed with wild abandon — and they’re doing it.

With study after study touting the benefits of marijuana for migraines, a 2019 study published by the American Pain Society had some of the biggest findings, with research showing a 50% decrease in migraine severity. 

It’s 2 o’clock on a Tuesday afternoon and the sharp pains clue you in to the inevitable — you’re getting a migraine. While many Americans suffer from migraines, very little information is on the market around why they occur and what truly can eliminate the affliction once and for all. So can marijuana help migraines?

A new series of tests conducted in Israel have shown that both CBC and CBG exhibit anti-tumour properties on cancer cells.

The test have been carried out by Cannabics Pharmaceuticals at the company’s High Through-put Screening (HTS) facility in Israel. The tests have shown that the cannabinoids CBC (Cannabichromene) and CBG (Cannabigerol) both exhibit anti-tumour properties after being tested on human Gastrointestinal Cancer Cells.